NOSCH LABS PRIVATE LIMITED

We main product/services:

• Enalapril Maleate
• Sumatriptan Succinate
• Intermediate Chemicals
• Sibutramine Hcl
• Tamsulosin Hcl
• Semi Finished Formulations
• Pharmaceutical Formulations
• Active Pharmaceutical Ingredients
• Almotriptan Malate
• Zolmitriptan
• Quetiapine Fumarate
• Lansoprazole
• Itraconazole
• Duloxetine Hcl
• Doxazosin Hcl
• Doxazosin Mesylate
• Pantoprazole Sodium Sesquihydrate
• Olanzapine(Form I Ii)

Company Profile:

Year Established:
Businss Type:	Manufacturer
Contact:	PRADIP CHOWDHURY G (DY.GM-MARKETING)
Telphone:	91-40-23154400
Fax	91-40-23154406
MobilePhone:	9948222287
Web Site:	www.noschlabs.net,
Zip:	500072
Country/Region:	India
Province/State:	Andhra Pradesh
City:	OPP: BJP Office, Kukatpally
Address:	Flat No. 404 to 406, Vijay Sai Towers

Introduce:

'Making the world a healthier place'

This is the dream that drives us at Nosch. The laudable goal that we aim for. The vision that suffuses us with the passion to innovate and excel.

Over the past seven years, we have been ceaselessly engaged in a quest to sustain and improve the quality of life through creating safe pharmaceutical solutions. Our competencies have grown to embrace the entire pharmaceutical value chain - APIs, Intermediates and Semi-finished Formulations.

Today, with an impeccable reputation for uncompromising quality and timely delivery, Nosch has emerged as the partner of choice of many transnational and multinational pharmaceutical companies in Asia, South America, Europe and the Middle East.

Production Prowess

Nosch's manufacturing operations span across 4 units in the south Indian state of Andhra Pradesh. While two are dedicated to API Unit, the other two are for Semi-finished Formulations/Pellets. The plants, built and operated in conformance with the latest cGMP norms, house R&D labs, technical services, quality control, quality assurance and regulatory affairs and are regularly inspected and approved by major customers from around the world.

The state-of-the-art equipment and instruments provide us the necessary competitive edge on the global state. Moreover, the infrastructure with its optimum installed capacities and capital costs, lends us a sustainable cost advantage.

R & D - An Eye to the Future

At present, our R&D activities are focused on process development. The sophisticated labs, manned by a talented, well-qualified team of professionals, develop proprietary processes for organic and custom-made intermediates. The department plays on active role in the selection of new products and charting non-infringing routes for manufacturing the same.

One of the main keys to Nosch's success has been the development and launch of products at the right time, in the right form and at the right price. An operation our R&D department enables us to perform to perfection, time after time!

Committed to Customer Delight

We believe in forging strong bonds with our customers through delivery of products on-time, cost--effectively and securely. Quick response time, comprehensive technical support and top-notch quality products have seen Nosch record a healthy turnover of 21 million, with export sales accounting for 16.2 million.

While the product portfolio is focused on Anti-ulceratives, which contribute to 50% of the company's turnover, we also have CTDs and Technical Documentation for many products.

Since the products are manufactured right from the basic to the penultimate stage, we are strategically positioned to supply any intermediate adhering to the customers specifications.

Map info

Send message to NOSCH LABS PRIVATE LIMITED

subject
Message
Login or Your Name Contact Email Contact Telephone Your Address

Send